Delivery of CRISPR/Cas9 for therapeutic genome editing – PubMed

The clustered, regularly-interspaced, short palindromic repeat (CRISPR)-associated nuclease 9 (CRISPR/Cas9) is emerging as a promising genome-editing tool for treating diseases in a precise way, and has been applied to a wide range of research in the areas of biology, genetics, and medicine. Deliver …

Read the full article here

Related Articles